REVIEW
Add like
Add dislike
Add to saved papers

Pathology of pulmonary thromboembolism.

Chest 1995 January
The incidence of pulmonary thromboembolism is hard to assess by the pathologist as a result of seasonal variation of embolism and disappearance of emboli by thrombolysis. However, the great differences in estimates of the incidence in routine hospital autopsies is mainly related to variation in scrutiny of the investigation and in size of area searched microscopically. Obstruction of major pulmonary arteries almost always results from thromboembolism which is most often found in its acute stage. In chronic major vessel embolism, arterial obstruction by an organized mass may produce pulmonary hypertension. Recanalization of such a mass results in so-called bands and webs. There are no reliable criteria to differentiate between emboli and primary thrombi or their sequelae. In peripheral, particularly muscular pulmonary arteries, thrombi are most likely primary, especially when associated with advanced age and with pulmonary hypertension. However, small arteries may be subject to extensive microembolism following fragmentation of large thromboemboli. Thrombotic arteriopathy is the pulmonary arterial disease based upon either primary thrombosis or embolism. It is often associated with pulmonary hypertension, and characterized by irregular, nonlaminar, often obliterative, intimal fibrosis. Recanalization channels, sometimes widening to separate intravascular fibrous septa, are characteristic features. Reversibility of post-thrombotic lesions is very limited.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app